Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847820 · ClinicalTrials.gov registry record
Clinical Evaluation of the AmniSure ROM Test
A clinical trial, sponsored by QIAGEN Gaithersburg.
- Terminated
- Registry status
- 383
- Enrollment target
NCT01847820 is a clinical trial that was terminated before completion, run by QIAGEN Gaithersburg. The registered enrollment target is 383 participants.
The verdict
NCT01847820 was terminated before completion, sponsored by QIAGEN Gaithersburg.
- TERMINATED
- Registry status
- 383 participants
- Enrollment target
Study Summary
To show that having less qualified personnel (non-Laboratory trained professionals) perform the test yields the same result as if a Laboratory trained professional performed the test.
Interventions
- DEVICE AmniSure ROM test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01847820
The ClinicalTrials.gov registry entry for NCT01847820 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 383 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QIAGEN Gaithersburg, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AmniSure ROM test is the first listed.
NCT01847820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01847820 about?
NCT01847820 is a clinical study titled "Clinical Evaluation of the AmniSure ROM Test". To show that having less qualified personnel (non-Laboratory trained professionals) perform the test yields the same result as if a Laboratory trained professional performed the test.
What is the current status of trial NCT01847820?
This trial is currently terminated. The enrollment target is 383 participants. The study started on 2013-08. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01847820?
The interventions under investigation include: AmniSure ROM test (DEVICE).
Who is sponsoring clinical trial NCT01847820?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.